Analysis of Preoperative Metabolic Risk Factors Affecting the Prognosis of Patients with Esophageal Squamous Cell Carcinoma: The Fujian Prospective Investigation of Cancer (FIESTA) Study

Some metabolic factors have been shown to be associated with an increased risk of esophageal cancer; however the association with its prognosis is rarely reported. Here, we assessed the prediction of preoperative metabolic syndrome and its single components for esophageal cancer mortality by analyzi...

Full description

Saved in:
Bibliographic Details
Published in:EBioMedicine 2017-02, Vol.16 (C), p.115-123
Main Authors: Peng, Feng, Hu, Dan, Lin, Xiandong, Chen, Gang, Liang, Binying, Zhang, Hejun, Dong, Xiaoqun, Lin, Jinxiu, Zheng, Xiongwei, Niu, Wenquan
Format: Article
Language:English
Subjects:
Aged
Carcinoma, Squamous Cell - complications
Carcinoma, Squamous Cell - mortality
Carcinoma, Squamous Cell - surgery
Esophageal Neoplasms - complications
Esophageal Neoplasms - mortality
Esophageal Neoplasms - surgery
Esophageal squamous cell carcinoma
Esophagus - metabolism
Esophagus - pathology
Esophagus - surgery
Female
FIESTA study
Humans
Kaplan-Meier Estimate
Male
Metabolic Diseases - complications
Metabolic risk factors
Metabolic syndrome
Middle Aged
Mortality
Multivariate Analysis
Outcome Assessment (Health Care) - methods
Outcome Assessment (Health Care) - statistics & numerical data
Preoperative Period
Prognosis
Proportional Hazards Models
Prospective Studies
Research Paper
Risk Factors
Sex Factors
Survival Rate
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Some metabolic factors have been shown to be associated with an increased risk of esophageal cancer; however the association with its prognosis is rarely reported. Here, we assessed the prediction of preoperative metabolic syndrome and its single components for esophageal cancer mortality by analyzing a subset of data from the ongoing Fujian prospective investigation of cancer (FIESTA) study. Between 2000 and 2010, patients who underwent three-field lymphadenectomy were eligible for inclusion. Blood/tissue specimens, demographic and clinicopathologic data were collected at baseline. Metabolic syndrome is defined by the criteria proposed by Chinese Diabetes Society. In this study, analysis was restricted to esophageal squamous cell carcinoma (ESCC) due to the limited number of other histological types. The median follow-up in 2396 ESCC patients (males/females: 1822/574) was 38.2months (range, 0.5–180months). The multivariate-adjusted hazard ratio (HR) of metabolic syndrome for ESCC mortality was statistically significant in males (HR, 95% confidence interval, P: 1.45, 1.14–1.83, 0.002), but not in females (1.46, 0.92–2.31, 0.107). For single metabolic components, the multivariate-adjusted HRs were significant for hyperglycemia (1.98, 1.68–2.33,
ISSN:2352-3964
2352-3964
DOI:10.1016/j.ebiom.2017.01.035